340B Drug Pricing Program Contributes to Rising Healthcare Costs and Is Ripe for Reform
The U.S. House Energy & Commerce Committee's Health Subcommittee today will host the third hearing in its health care affordability series, specifically examining the role providers and hospitals play in shaping the cost of care for Americans.
While the hearing will likely examine numerous issues, there is none more ripe for reform than the flawed 340B drug pricing program.
Originally enacted to help eligible safety-net providers buy medicines at steep discounts and pass the savings on to lower-income and vulnerable patients, the program has ballooned as a revenue stream for many participating hospitals and contract pharmacy chains.
As the size and complexity of the 340B program has expanded, participating hospitals and contract pharmacies have instead used the program to increase…[more]
In a 9-0 decision, the Supreme Court ruled states cannot use Section 3 of the 14th Amendment to kick former President Donald Trump off state ballots over his alleged "insurrectionist" actions on Jan. 6, 2021.
Learning that state officials aren't empowered to simply toss leading presidential candidates off ballots came as a great surprise to many incredulous left-wingers. Once you've convinced yourself Trump led a Hitlerian putsch that nearly overthrew democracy, every crackpot legal theory aimed at stopping him sounds not only morally justified but legally sound.
Just last week, progressives…